Amgen Inc (AMGN)
274.29
+0.75
(+0.27%)
USD |
NASDAQ |
Apr 24, 14:13
Amgen Total Assets (Quarterly): 97.15B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 97.15B |
| September 30, 2023 | 90.53B |
| June 30, 2023 | 90.27B |
| March 31, 2023 | 88.72B |
| December 31, 2022 | 65.12B |
| September 30, 2022 | 63.70B |
| June 30, 2022 | 59.29B |
| March 31, 2022 | 59.20B |
| December 31, 2021 | 61.16B |
| September 30, 2021 | 64.99B |
| June 30, 2021 | 59.77B |
| March 31, 2021 | 62.54B |
| December 31, 2020 | 62.95B |
| September 30, 2020 | 64.64B |
| June 30, 2020 | 65.01B |
| March 31, 2020 | 61.67B |
| December 31, 2019 | 59.71B |
| September 30, 2019 | 59.54B |
| June 30, 2019 | 59.37B |
| March 31, 2019 | 64.00B |
| December 31, 2018 | 66.42B |
| September 30, 2018 | 67.33B |
| June 30, 2018 | 67.68B |
| March 31, 2018 | 71.16B |
| December 31, 2017 | 79.95B |
| Date | Value |
|---|---|
| September 30, 2017 | 80.33B |
| June 30, 2017 | 79.59B |
| March 31, 2017 | 77.86B |
| December 31, 2016 | 77.63B |
| September 30, 2016 | 78.15B |
| June 30, 2016 | 75.47B |
| March 31, 2016 | 75.12B |
| December 31, 2015 | 71.45B |
| September 30, 2015 | 71.87B |
| June 30, 2015 | 71.21B |
| March 31, 2015 | 68.95B |
| December 31, 2014 | 69.01B |
| September 30, 2014 | 70.78B |
| June 30, 2014 | 69.53B |
| March 31, 2014 | 67.00B |
| December 31, 2013 | 66.12B |
| September 30, 2013 | 57.07B |
| June 30, 2013 | 52.61B |
| March 31, 2013 | 51.64B |
| December 31, 2012 | 54.30B |
| September 30, 2012 | 55.45B |
| June 30, 2012 | 52.23B |
| March 31, 2012 | 49.25B |
| December 31, 2011 | 48.87B |
| September 30, 2011 | 45.76B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
59.20B
Minimum
Mar 2022
97.15B
Maximum
Dec 2023
68.18B
Average
62.95B
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Gilead Sciences Inc | 62.12B |
| Johnson & Johnson | 167.56B |
| Eli Lilly and Co | 64.01B |
| Merck & Co Inc | 106.68B |
| Vertex Pharmaceuticals Inc | 22.73B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 90.92B |
| Shareholders Equity (Quarterly) | 6.232B |
| Debt to Equity Ratio | 10.37 |
| Current Ratio | 1.649 |
| Net Debt Paydown Yield | -3.36% |